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Neanderthal ancestry drives evolution of lipid
catabolism in contemporary Europeans
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Although Neanderthals are extinct, fragments of their genomes persist in contemporary
humans. Here we show that while the genome-wide frequency of Neanderthal-like sites is
approximately constant across all contemporary out-of-Africa populations, genes involved in
lipid catabolism contain more than threefold excess of such sites in contemporary humans of
European descent. Evolutionally, these genes show significant association with signatures of
recent positive selection in the contemporary European, but not Asian or African populations.
Functionally, the excess of Neanderthal-like sites in lipid catabolism genes can be linked with
a greater divergence of lipid concentrations and enzyme expression levels within this
pathway, seen in contemporary Europeans, but not in the other populations. We conclude
that sequence variants that evolved in Neanderthals may have given a selective advantage to
anatomically modern humans that settled in the same geographical areas.
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T
he ancestors of Neanderthals and modern humans
diverged from a common ancestral population B800–
400 thousand years ago (KYA)1–5. Subsequently,
Neanderthals evolved in Europe and Central Asia and possibly
spread further east into the Asian continent6. The first successful
migration of modern humans out of Africa can be traced back in
the archaeological and genetic records to B70–60 KYA7. After
that, modern humans spread quickly across all continents and
could have coexisted with Neanderthals in Europe and Central
Asia for thousands of years before the Neanderthal extinction
45–30 KYA7,8. Studies comparing the complete nuclear genome
sequences of Neanderthals and contemporary modern humans
indicate that out-of-Africa human populations, but not sub-
Saharan African populations, contain genomic regions with
unusually high similarity to the Neanderthal genome9,10. In each
individual, these regions were reported to occupy 1–4% of
the total genome sequence10. This phenomenon implies the
occurrence of gene flow from Neanderthals into those human
populations that migrated from the African continent11,12.
In this study, we asked whether genomic regions with high
sequence similarity to the Neanderthal genome are distributed
randomly across the genomes of contemporary modern humans.
If certain regions in the modern human genome show a decreased
Neanderthal gene flow, these regions may contain genetic changes
essential to the modern human phenotype that are undergoing
purifying selection against the Neanderthal alleles. By contrast,
the presence of genomic regions experiencing excessive gene flow
from Neanderthal may indicate that genetic changes that evolved
in Neanderthals gave modern humans carrying the Neanderthal
genotype a selective advantage.
We show that genetic variants shared between modern humans
and Neanderthals, but distinct from chimpanzees, are specifically
enriched in genes involved in lipid catabolism in contemporary
humans of European, but not East Asian descent. Excess of
Neanderthal variants in lipid catabolism genes was further
associated with signatures of recent positive selection. To assess
whether Neanderthal variants resulted in adaptive lipid
catabolism changes specific to Europeans, we measured lipidome
and transcriptome compositions of the brain tissue in con-
temporary humans of European, East Asian and African descent,
as well as in chimpanzees representing the ancestral state. In
agreement with observations made at the genome level, we show
significant excess of lipid concentration and gene expression
divergence in lipid catabolism pathways in Europeans, but not the
other population groups. Furthermore, lipid catabolism genes
showing increased expression divergence in Europeans contain an
even higher proportion of Neanderthal sites than other lipid
catabolism genes. Taken together, these observations indicate that
lipid catabolism of contemporary Europeans was partially shaped
by the genetic variants shared with Neanderthals. We further
speculate that these variants provided European ancestors with
adaptations to the geographic environment where Neanderthals
had evolved and where Neanderthals and archaic Europeans later
coexisted.
Results
Neanderthal ancestry in contemporary human populations. We
searched for regional similarities to the Neanderthal genome in
the genomes of 11 contemporary human populations, which have
the best genome coverage in the 1,000 genomes project: three
populations of African ancestry—HapMap African ancestry
individuals from South West of the United States (ASW), Luhya
individuals (LWK) and Yoruba individuals (YRI); three popula-
tions of East Asian ancestry—Han Chinese in Beijing (CHB), Han
Chinese from South China (CHS) and Japanese (JPT); and five
populations of European ancestry—CEPH individuals (CEU),
HapMap Finnish individuals from Finland (FIN), British indivi-
duals from England and Scotland (GBR), Iberian populations in
Spain (IBS) and Toscan individuals (TSI)13. For each pair of the
human populations, the human genome sequences were
compared with the Neanderthal and the chimpanzee genome
sequences. We used the high-coverage Neanderthal genome
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Figure 1 | Proportions of NLS in contemporary human populations. (a) Schematic representation of genomic distance calculations between contemporary
human populations and Neanderthals. The genomes of out-of-Africa individuals were compared with the genomes of individuals of purely African ancestry
(YRI). Single nucleotide differences from the Neanderthal genotype in an African genome were referred to as ‘ABBA’, while sites with the Neanderthal
genotype in an out-of-Africa genome were referred to as ‘BABA’. (b) Average proportions of NLS in contemporary African (AF), European (EU) and Asian
(AS) populations calculated based on sequence data from the 1,000 genomes project13; blue: genome wide (n¼ 1,158,559 sites), red: LCP genes (n¼498
sites). The error bars show the s.d. of the NLS proportion estimates. (c) Genomic distances between 11 contemporary human populations and
Neanderthals; blue, genome wide; red, LCP genes. The maximal bar length corresponds to a NLS frequency of 30%. Placement of ASWand CEU individuals
in sub-Saharan Africa and Western Europe, respectively, reflects their approximate historical geographical origins rather than their present location.
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2008 in the east gallery of Denisova Cave in the Altai mountains
(Altai)14,15, combined with the low-coverage Neanderthal
genome sequence, obtained from three individuals (Vindjia)10,
to reconstruct a consensus Neanderthal genome sequence by
excluding all sites with sequence variation among individuals. We
further used the reference chimpanzee genome in combination
with genome sequence data from 10 chimpanzees16 to exclude
sites variable among chimpanzees. Only single nucleotide sites
displaying sequence differences between the chimpanzee16,17 and
the two reference Neanderthal genomes10,15 were used in the
analysis (n¼ 1,158,559).
Similar to Green et al.10, we used the D statistic to detect
potential Neanderthal gene flow. For each pair of human
populations, we defined two configurations for genomic sites:
sites where the sequence of an individual from one human
population (population A) matched the Neanderthal rather than
chimpanzee genotype were assigned to the ABBA configuration;
and sites where the sequence of the other human population
(population B) matched the Neanderthal rather than chimpanzee
genotype were assigned to the BABA configuration (Fig. 1a).
For each population, the D statistic, which we will refer to as
the fraction of Neanderthal-like sites (NLS), was calculated as
the ratio of (#ABBA #BABA) to (#ABBAþ #BABA), where
# stands for the number of genomic sites in the specific genotype
configuration (ABBA or BABA; see Methods). While D-statistic
values reflect relative similarity between the Neanderthal and
the modern human genomes tested, they do not provide a
quantitative estimate of Neanderthal ancestry, that is, a 5%
D-statistic value reflects a higher similarity between population A
and Neanderthal compared with that for population B, but does
not signify a 5% level of Neanderthal ancestry in the population A
genome.
In agreement with previous observations10, the genomes of
contemporary humans of European and Asian descent showed
greater similarities to the Neanderthal genome than did the
genomes of the three populations of purely African descent. On
average, the NLS frequency was 6.1±0.2% for contemporary
humans of European and Asian descent, thus indicating a
substantial excess of NLS in contemporary out-of-Africa
populations (Fig. 1b,c, blue bars; Supplementary Tables 1–3).
This D-statistic estimate is similar to the ones reported by other
studies (4.8±0.2%)10, with the higher values obtained in our
study potentially arising from the additional filtering of genomic
sites polymorphic in Neanderthals. Further, in agreement with
other studies10, there was no substantial difference in the
genome-wide frequencies of NLS between European and Asian
populations, with a slight tendency for higher frequencies in
Asians: 5.9±0.08 and 6.2±0.06%, respectively18,19.
For each pair of human populations, we searched for the
presence of functional groups of genes showing an unusual
excess, or paucity, of NLS. This analysis, based on gene groups
compiled according to gene ontology terms20, and conducted
using the gene set enrichment analysis (GSEA) algorithm21,
yielded an unexpected observation; we indeed find significant
clustering of NLS in specific functional groups, but these
functional groups differed substantially between contemporary
European and Asian populations (Supplementary Data 1).
Functional groups showing NLS enrichment in Asian
populations mainly represent immune and haematopoietic
pathways. The strongest signal of NLS enrichment was,
however, observed in contemporary Europeans and included
two functional groups: the lipid catabolic process (LCP) and its
nested term—cellular LCP (GSEA, permutations Po0.01,
significance score 43; Fig. 2a). Specifically, genes in the LCP
term had the greatest excess of NLS in populations of European
descent, with an average NLS frequency of 20.8±2.6% versus
5.9±0.08% genome wide (two-sided t-test, Po0.0001, n¼ 379
Europeans and n¼ 246 Africans; Fig. 1b,c, red bars;
Supplementary Table 4; Supplementary Fig. 1). Further, among
examined out-of-Africa human populations, the excess of NLS in
LCP genes was only observed in individuals of European descent:
the average NLS frequency in Asians is 6.7±0.7% in LCP genes
versus 6.2±0.06% genome wide (Supplementary Table 4).
The excess of NLS observed in LCP genes for populations of
European descent was based on a large number of sites (n¼ 498),
and was robust to bootstrapping across sites (Po0.01, 1,000
bootstraps, Supplementary Table 5; Supplementary Fig. 2).
Notably, NLS were located in 23 independent genomic regions.
Among the remaining 15 LCP genes that did not contain NLS, 8
did not contain sites showing divergence between Neanderthals
and chimpanzees and the remaining 7 contained only a few such
divergent sites (Supplementary Table 6). It is furthermore robust
to the potential effects of DNA damage characteristic of ancient
DNA samples, as excluding the C/T and A/G substitutions that
may stem from deamination of cytosine residues in ancient
DNA22,23 did not affect the results (Supplementary Table 4).
Repeating the analysis using the genome sequences of African
(ASW, LWK, YRI), European (CEU, FIN, GBR, IBS) and East
Asian (CHB, JPT) individuals, which were sequenced to deeper
coverage at the pilot stage of the 1,000 genomes project, as well as
the high-coverage genome sequences of African (ASW, LWK,
YRI, MKK—Maasai in Kinyawa, Kenya), European (CEU, TSI)
and East Asian (CHB, JPT) individuals provided by the Complete
Genomics human diversity set24, confirmed our observations
(Supplementary Tables 7 and 8). Finally, repeating the analysis
using the high-coverage (Altai) and the low-coverage (Vindjia)
Neanderthal genomes, separately, resulted in similar findings
(Supplementary Table 9).
Adaptive signature of Neanderthal sequences in LCP genes.
The excess of NLS in LCP genes in the genomes of
contemporary Europeans may be due to a rapid spread of
Neanderthal alleles in European ancestors because of their
adaptive significance. Specifically, one may hypothesize that, over
time, Neanderthals acquired changes to lipid catabolism, which
were beneficial for survival in the environmental conditions of
prehistoric Europe and Central Asia. These adaptive variants may
then have been acquired by the modern humans through intro-
gression and rapidly brought to high frequency by positive
selection. To test this hypothesis, we searched for signatures of
positive selection in the genomes of contemporary humans of
European, Asian and African decent using composite of multiple
signals (CMS) scores25. High CMS values indicate genomic
regions under recent positive selection based on three distinct
signatures of selection: long-range haplotypes, differentiated
alleles and high-frequency-derived alleles. We indeed found a
significant excess of high CMS scores in the LCP gene regions of
contemporary Europeans but not Asians or Africans (Fig. 2b).
This effect was robust at different CMS score cutoffs and
was specific to LCP: no significant excess of high CMS
scores in individuals of European descent was observed in
comparable genomic regions containing other metabolic genes
(Supplementary Fig. 3). Furthermore, within the LCP term, high
CMS scores found in contemporary Europeans were associated
with genes containing the excess of NLS, but were not associated
with other LCP genes (two-sample Wilcoxon test, P¼ 0.0003;
n¼ 45 and 20; Supplementary Fig. 4).
Metabolic changes associated with Neanderthal ancestry. The
observed signatures of positive selection suggest that genetic var-
iants shared with Neanderthals resulted in adaptive changes in
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lipid catabolism in Europeans, but not in Asians. At a physiological
level, these adaptive changes should affect the concentrations of
LCP metabolites, and the expression levels of the corresponding
metabolic enzymes, in a manner specific to Europeans. To test this,
we analysed the lipid composition of prefrontal cortex (PFC) tissue
in 14 adult humans of European, African and Asian descent, as
well as 14 adult chimpanzees (Supplementary Data 2) using
C8-reversed phase liquid chromatography coupled to high-resolu-
tion mass spectrometry26,27. Out of 4,243 detected mass
spectrometric peaks, 1,314 could be computationally matched to
lipid compounds belonging to 63 metabolic categories using
metabolite annotation databases28,29. After elimination of low
confidence matches supported by less than 5 mass spectrometric
peaks, 16 metabolic categories, containing 1,253 peaks, remained
and were used in further analyses (Fig. 3a; Supplementary Data 2).
Seven of these 16 metabolic categories were directly linked with
genes in the LCP term (Supplementary Table 10) based on Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway annota-
tion30. In Europeans, the concentrations of lipids within these
seven metabolic categories linked with LCP were more diverged
from chimpanzees than the concentrations of lipids in the other
nine metabolic categories not linked with LCP (qo0.0001; q
value shows the proportion of the LCP divergence values that
were smaller than, or equal to, the divergence values in other
metabolic categories). By contrast, in contemporary Africans or
Asians there were no differences between the concentration
divergence of lipids associated with LCP and the lipids associated
with other metabolic categories (q40.1; Fig. 3b). This result was
not driven by one or several metabolites, but represented a
general property of this metabolite group, as shown by bootstrap
analysis (qo0.0001) Further, this result was not caused by
differences among population samples with respect to age, sex,
tissue preservation or postmortem delay (Supplementary
Table 11; Supplementary Fig. 5). We note that, while we cannot
control for environmental differences among populations, our
analysis is based on the relative divergence of seven metabolic
categories associated to LCP and was normalized to the
divergence of the other nine metabolic categories not associated
with LCP within the same population. This normalization
removes the influence of environmental factors affecting LCP
and non-LCP metabolites to the same extent. Furthermore, our
study design provides no indications that environmental effects
should be particular to Europeans: all individuals of European
and African descent used for lipidome analysis came from the
same region within the United States, while all individuals of
Asian descent came from central China.
Expression changes associated with Neanderthal ancestry. We
next asked whether the greater concentration divergence of LCP
metabolites observed in Europeans could be linked to a similarly
accelerated expression level divergence of the corresponding
enzymes. To test this, we measured gene expression levels in the
14 human PFC samples used in the lipid analysis, as well as 6 out
of 14 chimpanzee PFC samples, using high-throughput RNA
sequencing (RNA-seq). For each sample, we obtained an average
of 15 million reads, 85% of which could be mapped31 uniquely to
the corresponding genome (Fig. 3c; Supplementary Table 12;
Supplementary Fig. 6). Using KEGG pathway annotation, six
genes annotated in the LCP term and detected in the RNA-seq
data could be directly linked to the seven LCP metabolic
categories (Supplementary Table 10). For these six genes the
expression divergence from chimpanzees, relative to
the expression divergence of other LCP genes expressed in PFC,
was the largest in Europeans (qo0.0001; q value shows the
proportion of the divergence values that were smaller than, or
equal to, the divergence values in other LCP genes), intermediate
in Asians (q¼ 0.04) and absent in Africans (q¼ 0.59; Fig. 3d;
Supplementary Fig. 6). This result was robust, as shown by
bootstrap analysis, and was not caused by differences in age, sex,
RNA quality or postmortem delay among the three human
populations (Supplementary Fig. 7). Thus, accelerated metabolic
divergence in the LCP term found in Europeans appears to be
linked to an accelerated expression level divergence of the
corresponding metabolic enzymes.
Notably, the gene regions of the six LCP enzymes linked to
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Figure 2 | Outstanding genetic features of lipid catabolism genes. (a) Clustering of NLS in functional categories in the genomes of contemporary humans
of European (EU) and Asian (AS) descent. The significance scores are proportional to the NES and inversely proportional to the false discovery rates
calculated for each gene ontology (GO) term in the biological process category using the GSEA algorithm. Sizes of circles and squares represent NLS
fractions in Europeans and Asians, respectively, for each GO term. Numbers near the circles mark the top two GO terms with a functional enrichment
significance score greater than three, based on the distribution of Neanderthal-like genomic sites in Europeans: (1) LCP, (2) cellular LCP. (b) Positive
selection signals in LCP gene regions estimated using CMS scores. Black squares represent the frequency of sites with elevated CMS scores (41),
potentially indicating genomic regions under recent positive selection in LCP gene regions, normalized by the frequency of such sites in all annotated genes
within the same population. The boxplots show the variation of normalized site frequency estimates obtained by 1,000 bootstraps over LCP gene regions
(n¼ 38). The boxes show quartiles and the median of the data, the whiskers extend to the minimum and maximum data values located within 0.5
interquartile range from the box. The numbers above the boxplots show the proportion of bootstrap values where the normalized site frequency of elevated
CMS scores in Africans (AF) or Asians (AS) was greater than, or equal to, the normalized site frequency in Europeans (EU).
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proportion of NLS in Europeans (31.6±4.1%) than all LCP genes
(20.8±2.6%). Furthermore, these NLS were not distributed
uniformly within the gene regions, but clustered in the vicinity
of transcription start sites, suggesting that they may have a role in
causing gene expression level changes seen in Europeans (two-
sample Wilcoxon test, P¼ 0.048; n¼ 14 and 27; Supplementary
Fig. 8). By contrast, individuals of Asian and African descent did
not show any significant excess of NLS within the same gene
regions (Fig. 4a).
Possible functional implications of changes in LCP. While we
find changes in lipid catabolism particular to Europeans at the
metabolite concentration and enzyme expression levels, the sig-
nificance of these changes at the organismal level remains to be
investigated. Still, the changes observed at the molecular level
provide some clues. Among the seven metabolic categories
associated with LCP, 2-lysophosphatidylcholine has been impli-
cated in a number of functions, including reactive oxygen species
generation, apoptotic and non-apoptotic death, as well as glucose-
dependent insulin secretion32 (Fig. 4b,c). Furthermore, genetic
variants linked to obesity (DAVID33, Fisher’s exact test, Po0.01
after multiple testing correction, n¼ 38) hypertriglyceridemia and
coronary heart disease, as well as triglycerides and cholesterol
levels (DAVID, Fisher’s exact test, Po0.01 after multiple testing
correction, n¼ 38) in genome-wide association studies34 show a
significant enrichment of LPC genes containing an excess of NLS
(Supplementary Table 13). Notably, frequencies of these diseases
have been shown to differ between individuals of European
descent and other human populations35. These observations
support a contribution of Neanderthal genetic variants to the
phenotype of contemporary Europeans.
Discussion
Our results show that NLS—genetic variants shared between
modern humans and Neanderthals, but distinct from
chimpanzees—are specifically enriched in genes involved in lipid
catabolism in contemporary humans of European descent.
Signatures of recent positive selection associated with lipid
catabolism genes containing NLS in contemporary Europeans
further indicate that these genetic variants may have been swept
to high frequency by positive selection. This notion presumes the






























































































Figure 3 | Lipid concentration and gene expression divergence in LCP and other metabolic pathways. (a) Principal component analysis based on
normalized intensities of 1,314 annotated mass spectrometric peaks corresponding to 63 metabolic categories. Each circle represents an individual: blue,
Asians; grey, Africans; red, Europeans; black, chimpanzees. (b) The distribution of lipid concentration divergence estimates measured between
chimpanzees and humans of African (AF, n¼4 individuals), Asian (AS, n¼ 5 individuals) and European (EU, n¼ 5 individuals) descent for metabolic
categories directly linked to LCP genes (red, n¼ 1,090 mass spectrometric peaks) and metabolites in other metabolic pathways (grey, n¼ 163 mass
spectrometric peaks). To minimize the influence of environmental differences among populations, metabolic divergence in the LCP term was normalized
to the divergence of all other metabolic pathways within the same population. The numbers above the red boxplots show the proportion of values from
the LCP divergence distribution obtained by 1,000 bootstraps over individuals within populations that were smaller than, or equal to, the divergence
values calculated based on other metabolic pathways represented by the grey boxplots. All boxes in this and the other panels show quartiles and the
median of the data, the whiskers extend to the minimum and maximum data values located within 0.5 interquartile range from the box. (c) Principal
component analysis based on the expression levels of 25,813 genes. Each circle represents an individual; colours are as in panel a. (d) The distribution
of gene expression divergence estimates measured between chimpanzees and human populations for LCP genes directly linked to seven metabolic
categories shown in panel b (red, n¼6 expressed genes) and other LCP genes (grey, n¼ 26 expressed genes). Normalization procedure and
significance estimation were conducted the same way as for metabolite data presented in panel b.
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ancestry. Our analysis of lipid concentration and enzyme
expression levels in brain samples of chimpanzees and con-
temporary humans of African, East Asian and European decent
supports this assumption. Specifically, we show an increased lipid
concentration and enzyme expression divergence between
Europeans and the ancestral state exemplified by chimpanzees
in lipid catabolism pathways compared with other metabolic
pathways. Finally, we show that lipid catabolism genes showing
increased expression divergence in Europeans contain an even
higher proportion of NLS than other lipid catabolism genes,
and these NLS are located in closer proximity to the genes’
transcriptional start sites than would be expected by chance.
It is appealing to speculate that genetic variants affecting lipid
catabolism in modern Europeans were acquired by modern
human ancestors through genetic flow from Neanderthals, and
then spread rapidly though the ancestral population by means of
positive selection. Action of positive selection could be further
explained by the adaptive significance of these variants in the
geographic environment where Neanderthals had evolved and
where Neanderthals and archaic Europeans later coexisted. It is
noteworthy, however, that our observations are compatible with
both introgression and incomplete lineage sorting hypotheses
explaining the excess of genetic variants shared between
contemporary humans and Neanderthals in out-of-Africa
populations. Furthermore, while the excess of NLS in lipid
catabolism genes is not observed in East Asian populations, we
cannot assume that it is specific to Europeans. Complete genome
sequences from a larger spectrum of human populations,
especially from geographical regions coinciding with the
Neanderthal living range, are needed to determine the full
geographical spectrum of this effect. This is particularly true,
given the fact that the Neanderthal area included Asian regions,
such as the Altai Mountains. Still, the absence of NLS frequency
increase in lipid catabolism genes in East Asian populations
accompanied by no increase in the lipid concentration and
enzyme expression divergence in the corresponding pathways
indicates the geographical specificity of this phenomenon.
One further argument indirectly supporting geographical
specificity and local adaptive significance of the lipid catabolism
changes potentially induced by Neanderthal variants comes from
a comparison with the genome of another archaic human
species—Denisovans36. Analysis of lipid catabolism gene
sequences with the Denisova genome revealed a higher
frequency of sites shared between Neanderthals and moderns
humans, derived respective to both the chimpanzees and
Denisovans, in contemporary Europeans than in East Asians
(Supplementary Table 14). Notably, no such difference was
observed in the genome-wide analysis. This result shows that
changes in lipid catabolism genes shared between Neanderthals
and contemporary Europeans were not fully present in
Denisovans. Given that the presumed geographical area of
Denisovans includes most of Asia36, this result indirectly
supports specificity of observed lipid catabolism change to the
European part of the Eurasian continent.
We further note that a high frequency of NLS in lipid
catabolism genes of contemporary Europeans does not require
introgression, but is compatible with alternative scenarios. For
instance, an alternative explanation of the general increase in NLS
frequency in humans outside Africa, postulating the existence of a
complex population structure within the African continent at
the time of human and Neanderthal lineage divergence, has
been hypothesized4. This hypothesis explains the presence of
Neanderthal variants in non-African human populations by
shared ancestry specific to ancestral human populations that left
the African continent. If the lipid catabolism gene variants we
find in Neanderthals and contemporary Europeans were already
present in the ancestors of Neanderthals and out-of-Africa
human populations, they may have independently increased in
frequency in Neanderthals and humans situated in the European
region. This scenario is probable if these genetic variants provided
an adaptive advantage to both Neanderthal and human
populations in the conditions of prehistoric Europe. While the
presence of a recent positive selection signal in lipid catabolism
gene variants containing NLS in modern Europeans supports
such an adaptive scenario, the environmental pressures or
functional mechanisms of this possible adaptive change remain
0.35
























































Figure 4 | Potential regulatory effects of NLS in LCP pathway.
(a) Average proportions of NLS in contemporary African (AF), European
(EU) and Asian (AS) populations calculated based on sequence data from
the 1,000 genomes project13; blue, genome wide (GW, n¼ 1,158,559 sites);
red, all LCP genes (n¼498 sites); black, LCP genes connected to
European-specific metabolic changes (MC, n¼ 114 sites). The error bars
show the s.d. of the NLS proportion estimates. (b) Relative concentration
levels of 2-lysophosphatidylcholine, in three contemporary human
populations and in chimpanzees (CH). The boxplots represent the median
and the variation of normalized, z-transformed metabolite concentrations in
each sample group calculated by 1,000 bootstraps over individuals within
populations (n¼ 11 mass spectrometric peaks). The *** indicates
significance of 2-lysophosphatidylcholine concentration difference between
European (n¼ 5) and chimpanzee (n¼ 14) individuals (Po0.001)
estimated by the bootstrapping procedure. (c) Gene expression levels of
genes directly linked with 2-lysophosphatidylcholine according to KEGG
annotation, in the three human populations and chimpanzees. The boxplots
are as in panel b. The *** indicates significance of expression difference
between European (n¼ 5) and chimpanzee (n¼ 6) individuals (Po0.001)
for genes directly linked with 2-lysophosphatidylcholine (n¼ 21) estimated
by the bootstrapping procedure.
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elusive. Further studies of LCP conducted across multiple tissues
and multiple contemporary human populations are needed to
more fully assess the potential functional effects of this event.
Methods
D-statistic calculation. The genome sequences of individuals in 11 contemporary
human populations, ASW, CEU, CHB, CHS, FIN, GBR, IBS, JPT, LWK, TSI and
YRI were obtained from the 1,000 genomes project (release 2011.05.21)13. The
genome sequence reads from 10 chimpanzee individuals were obtained from ref. 16
and mapped to the panTro2 reference genome. The sites polymorphic among
chimpanzees were identified using GATK program17 with filtering parameters
DPo30, DP4180, MQ0440, (MQ0/(1.0*DP))40.40, ANo16, MQo25. This
procedure identified 323,948 polymorphic sites that were removed from further
analyses. The non-overlapping genome sequence contigs representing the Vindija
Neanderthal genomes were obtained from the UCSC genome browser. The Altai
Neanderthal genome contigs were obtained from http://www.eva.mpg.de/
neandertal/index.html15. For both genomes, 4,360,373 sites were removed
following the filtering procedure described in ref. 10. Coordinates of the
chimpanzee and Vindija Neanderthal sequences were mapped to the human
reference genome hg19 using the UCSC liftover tool with default parameters. A
total of 411,783 polymorphic sites identified in a comparison between Vindija and
Altai Neanderthal sequences were removed from further analysis.
To estimate similarity between the Neanderthal genome and the genomes of
contemporary humans, we applied the following procedure to all possible pairs of
contemporary human populations. The following procedure was applied to each
pair of populations (Pop1 and Pop2). We randomly selected two individuals from
populations Pop1 and Pop2—Ind1 and Ind2, respectively. Only sites with different
genotypes in chimpanzee (A) and Neanderthal (B) were considered. We calculated
#BABA as the number of sites where Ind1¼B, Ind2¼A (and neand.¼B,
chimp.¼A) and #ABBA as the number of sites where Ind1¼A, Ind2¼B
(and neand.¼B, chimp.¼A). Then, D score was calculated as following:
(#ABBA #BABA)/(#ABBAþ #BABA). To estimate the proportions of NLS for
populations Pop1 and Pop2, D score was calculated for all possible pairs of
individuals Ind1 and Ind2, and then averaged across these pairs.
Functional analysis of gene groups. The GSEA program21 was applied to find
functional gene groups with a significant enrichment or depletion of NLS in out-of-
Africa human populations. All out-of-Africa human populations were compared
with a purely African population YRI. We calculated #ABBA and #BABA for each
pair of individuals (one from out-of-Africa population, another from YRI). The
GSEA program ranks genes according to a difference between two values (#ABBA
and #BABA), and each value can have several replicates. We treated each pair of
individuals as a replicate, which was reasonable because our pairs of individuals
were independent. To make the pairs of individuals independent (and also to lower
their number and save the calculation time), pairs of individuals were composed in
such a way that one individual could participate in one pair only.
We used two key statistics that GSEA reported for the gene set enrichment
analysis: normalized enrichment score (NES) and false discovery rate to calculate
the GSEA significance score. NES is the actual enrichment score divided by the
mean of enrichment scores against all permutations of the data set to account for
the differences in gene set size. False discovery rate is the estimated probability that
a gene set with a given NES represents a false-positive finding. In all GSEA
analyses, we used MSigDB collection21 of 825 gene ontology biological process gene
sets (http://www.broadinstitute.org/gsea/msigdb/download_file.jsp?filePath=/
resources/msigdb/3.0/c5.bp.v3.0.symbols.gmt) as an annotation database.
Samples used for metabolite and RNA-seq experiments. Chimpanzee samples
were obtained from the Anthropological Institute and Museum of the University
of Zu¨rich-Irchel, Switzerland, the Yerkes Primate Center, GA, USA and the
Biomedical Primate Research Centre, the Netherlands. All chimpanzees used in
this study suffered sudden deaths for reasons other than their participation in this
study and without any relation to the tissue used. Human samples were obtained
from the NICHD Brain and Tissue Bank for Developmental Disorders at the
University of Maryland and the Chinese Brain Bank Center. All subjects suffered
sudden death with no prolonged agonal state. They were defined as healthy
controls by forensic pathologists at the corresponding tissue bank. Specific
permission for brain autopsy and use of the brain tissue for research purpose was
given by the donors or their relatives. Use of human autopsy tissue is considered
non-human-subject research and is institutional review board exempt under the
National Institutes of Health guidelines.
The samples were dissected from frozen postmortem tissue on dry ice.
The frontal part of the superior frontal gyrus, a cortical region approximately
corresponding to Brodmann area 10, was used for dissection. The tissue samples
were first powdered using a mortar and pestle cooled by liquid nitrogen and next
separated in two parts for metabolite and RNA extraction procedures. Each sample
was B100mg in weight.
Metabolite sample preparation and measurement. Metabolites were extracted
from the frozen brain tissue powder by methanol: methyl-tert-butyl-ether
(1:3 (v/v)) extraction26,27. In brief, 50mg of frozen powdered PFC tissue was
re-suspended in 1ml extraction solution containing two internal standards
(0.5 mg of corticosterone and 1.5 mg of 1,2-diheptadecanoyl-sn-glycero-3-
phosphocholine (PC 34:0)). The samples were incubated for 10min at 4 C on an
orbital shaker, before subjecting them to ultrasonication for 10min in an ice-cooled
bath-type sonicator. The insoluble tissue material (including proteins) was pelleted
by a centrifugation step (5min; 14,000g) and the supernatant was transferred to a
fresh 2ml Eppendorf tube. To separate the organic from the aqueous phase, 500 ml
of an H2O:methanol mixture (3:1(v/v)) was added to the supernatant, mixed
by vortexing and centrifuged (5min; 14,000g). Five hundred microlitres of the
upper methyl-tert-butyl-ether-phase was transferred to a 1.5-ml Eppendorf tube,
concentrated in a speed vacuum and re-suspended in 100ml of an
acetonitrile:isopropanol mixture (7:3 (v/v)) before liquid chromatography–mass
spectrometry analysis. For the analysis, 5 ml of lipid extract was injected onto the
ultra performance liquid chromatography C8-reversed phase column (BEH C8,
Waters), connected to an Orbitrap Exactive mass spectrometer26,27.
Metabolite data pre-processing and analysis. Mass spectrometric peaks that
had zero values within one of the sample groups (European, Chinese, African
American or chimpanzee) were directly removed from the resulting matrix because
of inconsistency between the replicates. Lipid metabolite data were then normal-
ized for the internal standard (PC 34:0), log scaled and then quantile normalization
was applied. Each peak intensity value was z-transformed. The resulting 4,243
spectrometric peaks were preliminarily annotated using database searches against
the HMDB and LipidMaps databases27–29. These searches, which were based on
pure mass to charge (m/z) ratio matches of the mass that was spectrometrically
measured and the theoretical masses of the lipids in the above-mentioned
databases, were performed with an m/z tolerance of 10 p.p.m., allowing different
ionization adducts27. A total of 2,111 mass spectrometric peaks could thus
be assigned to known metabolites in the HMDB and LipidMaps database and
1,314 of these could be linked to the KEGG database via the corresponding
compound ID. Principal component analysis was performed using the ‘prcomp’
R function for all peaks linked to the KEGG database using normalized data before
z-transformation.
If several peaks could be assigned to the same metabolic category, a median
across these peaks was used as the metabolite category concentration value.
Metabolic categories that could be assigned fewer than five peaks were removed
from further analysis. For each metabolite, a median value was calculated within
European, Chinese, African American and chimpanzee sample groups. The
metabolite divergence between European, Chinese, and African American
populations and chimpanzees was calculated as an absolute difference between the
chimpanzee and human values.
To test the robustness of metabolite divergence estimates, we bootstrapped the
individuals within populations 1,000 times. As a result, we obtained two divergence
distributions: (i) for metabolic categories directly linked to the LCP pathway
according to KEGG annotation (KEGG metabolism pathways only were used) and
(ii) for all other metabolites detected in the PFC. One-sided P values were
calculated as the proportion of values from the distribution (i) that were smaller
than, or equal to, the actual value for the distribution (ii).
RNA-seq sample preparation and measurement. Total RNA was isolated using
Trizol reagent (catalogue number 15596-026, Invitrogen). The libraries were
constructed from the isolated total RNA according to the ‘TruSeq RNA Sample
Preparation Kit’ protocol (http://www.illumina.com) without modification. As the
protocol includes the procedure of enrichment for messenger RNA, an additional
polyA selection was not necessary. Samples were sequenced on the Illumina HiSeq
2,000 system, using the 100-bp single-end sequencing protocol.
RNA-seq data pre-processing and analysis. Human reads were mapped using
Tophat31 (parameters were set to -a 8 -m 2 no-coverage-search microexon-search
segment-mismatches 3 segment-length 25) to the hg19 reference genome.
Chimpanzee reads were mapped to the panTro3 reference genome using the same
procedure. To match human and chimpanzee gene annotations, we used a
reciprocal liftover to map the human annotation to the chimpanzee genome
(Ensembl annotation v. 69). Only exons that could be matched between the two
genomes by reciprocal liftover were used to calculate gene expression intensities
(RPKM). Gene expression values were further normalized by quantile
normalization and z-transformation across all samples. Principal component
analysis was performed using the ‘prcomp’ R function for all genes using
normalized data before z-transformation.
For gene expression divergence calculations, a median value was calculated
within European, Chinese, African American and chimpanzee sample groups.
The distance from European, Chinese and African American populations to
chimpanzee was calculated as an absolute difference between chimpanzee and
human values. To test the robustness of gene expression divergence measurements,
we bootstrapped individuals within populations 1,000 times, and obtained two
distributions: (i) for genes directly linked to LCP metabolites according to KEGG
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annotation (KEGG metabolism pathways only were used); and (ii) for all other
LCP genes expressed in the PFC. One-sided P values were calculated as the
proportion of values from the distribution (i) that were smaller than, or equal to,
the actual value for the distribution (ii).
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